Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 64.84 USD -3.76% Market Closed
Market Cap: 4.1B USD

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 85.09 USD with a low forecast of 72.72 USD and a high forecast of 98.7 USD.

Lowest
Price Target
72.72 USD
12% Upside
Average
Price Target
85.09 USD
31% Upside
Highest
Price Target
98.7 USD
52% Upside
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
4584
Kidswell Bio Corporation
37% Upside
VCYT
Veracyte Inc
51% Upside
MNKD
MannKind Corp
170% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
34% Upside
2616
CStone Pharmaceuticals
40% Downside
TRDA
Entrada Therapeutics Inc
206% Upside
INCY
Incyte Corp
10% Upside
ORKA
Oruka Therapeutics Inc
225% Upside

Revenue
Forecast

Revenue Estimate
Rhythm Pharmaceuticals Inc

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 63%.

N/A
Past Growth
63%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
85.09 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 85.09 USD with a low forecast of 72.72 USD and a high forecast of 98.7 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
63%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 63%.

Back to Top